The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells
European Journal of Cancer, 08/08/2012
Alonzeau J et al. – The present data indicate that 26RFa may participate to the development of prostate cancer (CaP) at the androgeno–independent (AI) state by promoting the neuroendocrine differentiation and the migration of cancer cells via autocrine/paracrine mechanisms.



